April 15, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology

SANTA CLARA, Calif., April 15, 2021  Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further... Read more

March 2, 2021 Clinical Research/Diagn. M&A, Partnerships

Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics

SANTA CLARA, Calif., March 02, 2021  Highlights: Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with Agilent’s leadership in tissue-based companion diagnostics and global commercial and regulatory scale. Furthers Agilent’s participation in fast-growing NGS technologies for precision... Read more